b 35 719
Pill imprint b 35 719 has been identified as Alendronate sodium 35 mg.
Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy.
Alendronate 35 mg is not subject to the Controlled Substances Act.
See also related documents.
Alendronate sodium Images
- Imprint:
-
b 35
719 - Strength:
- 35 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
magnesium stearate
mannitol
microcrystalline cellulose
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0719
Advertisement
More Alendronate Sodium resources
- Alendronate (Wolters Kluwer)
- Alendronate Solution (Wolters Kluwer)
- alendronate (Cerner Multum)
- alendronate (Micromedex) - Includes Dosage Information
- Alendronate Sodium (AHFS DI)
- Alendronate (FDA)
- Alendronate Sodium (Wolters Kluwer)
Search Again
